KHOZEMA CAMPWALA: Open Payments
NPI 1376564450 · VENTURA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,331 in 71 payments from 15 companies in 2025. Trend: 2023 $1,242 · 2024 $1,266 · 2025 $1,331
Food & beverage: $1,331
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $295 |
| AstraZeneca Pharmaceuticals LP | 10 | $203 |
| Lilly USA, LLC | 8 | $173 |
| ABBVIE INC. | 9 | $152 |
| Amgen Inc. | 11 | $142 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $78 |
| Dexcom, Inc. | 3 | $56 |
| PFIZER INC. | 3 | $56 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Teleflex LLC | 1 | $32 |
Products named: MOUNJARO, AIRSUPRA, Ozempic, VRAYLAR, Wegovy, JARDIANCE, OTEZLA, EVENITY.
Industry payments across CA — which companies pay providers there.
